IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Therapeutic Advances in Infectious Disease

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.28

h-Index

2024-2025

 34

Rank

2024-2025

 3571

SJR

2024-2025

 1.197

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Therapeutic Advances in Infectious Disease
Abbreviation Ther. Adv. Infect. Dis.
Publication Type Journal
Subject Area, Categories, Scope Infectious Diseases (Q1); Pharmacology (medical) (Q1)
h-index 34
Overall Rank/Ranking 3571
SCImago Journal Rank (SJR) 1.197
Impact Score 3.28
Publisher SAGE Publications Inc.
Country United Kingdom
ISSN 2049937X, 20499361
Best Quartile Q1
Coverage History 2013-2025




About Therapeutic Advances in Infectious Disease


Therapeutic Advances in Infectious Disease is a journal covering the technologies/fields/categories related to Infectious Diseases (Q1); Pharmacology (medical) (Q1). It is published by SAGE Publications Inc.. The overall rank of Therapeutic Advances in Infectious Disease is 3571. According to SCImago Journal Rank (SJR), this journal is ranked 1.197. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 34. The best quartile for this journal is Q1.

The ISSN of Therapeutic Advances in Infectious Disease journal is 2049937X, 20499361. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Infectious Disease is cited by a total of 851 articles during the last 3 years (Preceding 2024).


Therapeutic Advances in Infectious Disease Impact IF 2024-2025


The Impact IF 2024 of Therapeutic Advances in Infectious Disease is 3.28, which is computed in 2025 as per its definition. Therapeutic Advances in Infectious Disease IF is increased by a factor of 0.03 and approximate percentage change is 0.92% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Therapeutic Advances in Infectious Disease Impact IF 2025 Prediction


Impact IF 2024 of Therapeutic Advances in Infectious Disease is 3.28. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Therapeutic Advances in Infectious Disease. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.28
2023 3.25
2022 4.04
2021 3.49
2020 3.26
2019 3.14
2018 5.52
2017 7.00
2016 2.67
2015 2.00
2014 0.79

Therapeutic Advances in Infectious Disease h-index


  Table Setting

Therapeutic Advances in Infectious Disease has an h-index of 34. It means 34 articles of this journal have more than 34 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Therapeutic Advances in Infectious Disease ISSN


The ISSN of Therapeutic Advances in Infectious Disease is 2049937X, 20499361. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Therapeutic Advances in Infectious Disease Rank and SCImago Journal Rank (SJR)


The overall rank of Therapeutic Advances in Infectious Disease is 3571. According to SCImago Journal Rank (SJR), this journal is ranked 1.197. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Therapeutic Advances in Infectious Disease by Year


Year SJR
2025/2026 Coming Soon
2024 1.197
2023 1.015
2022 1.341
2021 0.633
2020
2019
2018
2017 1.065
2016 1.074
2015 0.477
2014 0.209

Ranking of Therapeutic Advances in Infectious Disease by Year


Year Ranking
2025/2026 Coming Soon
2024 3571
2023 4353
2022 2585
2021 7762
2020 34876
2019 32621
2018 34080
2017 4004
2016 3970
2015 9571
2014 16695

Therapeutic Advances in Infectious Disease Publisher


Table Setting

Therapeutic Advances in Infectious Disease is published by SAGE Publications Inc.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2013-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Therapeutic Advances in Infectious Disease is Ther. Adv. Infect. Dis.. This abbreviation ('Ther. Adv. Infect. Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Therapeutic Advances in Infectious Disease


If your research field is/are related to Infectious Diseases (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Therapeutic Advances in Infectious Disease?

Therapeutic Advances in Infectious Disease latest impact IF is 3.28. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 7.00 (2017) and 0.79 (2014), respectively, in the last 11 years. Moreover, its average IS is 3.49 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Therapeutic Advances in Infectious Disease?

The Therapeutic Advances in Infectious Disease has an SJR (SCImago Journal Rank) of 1.197, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.341 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the Therapeutic Advances in Infectious Disease over the previous 11-year period stands at 3.49.


What's the latest h-index of the Therapeutic Advances in Infectious Disease?

The latest h-index of the Therapeutic Advances in Infectious Disease is 34.


Who's the publisher of the Therapeutic Advances in Infectious Disease?

The Therapeutic Advances in Infectious Disease is published by the SAGE Publications Inc., with its country of publication being the United Kingdom.


What's the current ranking of the Therapeutic Advances in Infectious Disease?

The Therapeutic Advances in Infectious Disease is currently ranked 3571 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2585 in 2022 and its lowest position of 34876 in 2020.


What's the abbreviation or short name for the Therapeutic Advances in Infectious Disease?

The standard ISO4 abbreviation for the Therapeutic Advances in Infectious Disease is Ther. Adv. Infect. Dis..


Is the "Therapeutic Advances in Infectious Disease" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Therapeutic Advances in Infectious Disease is classified as a journal that the SAGE Publications Inc. publishes.


What's the scope or major areas of the Therapeutic Advances in Infectious Disease?

The Therapeutic Advances in Infectious Disease encompasses the following areas:

  • Infectious Diseases
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Therapeutic Advances in Infectious Disease?

The Therapeutic Advances in Infectious Disease is assigned the following International Standard Serial Numbers (ISSN): 2049937X, 20499361.


What's the best quartile of the Therapeutic Advances in Infectious Disease?

The best quartile for the Therapeutic Advances in Infectious Disease is Q1 (2024).


What's the coverage history of the Therapeutic Advances in Infectious Disease?

The Therapeutic Advances in Infectious Disease coverage history can be summarized as follows: 2013-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 9811 Vilnius Gediminas Technical University 55 2.84
Indian Journal of Plastic Surgery journal 30965 Georg Thieme Verlag 44 0.46
Applied Ecology and Environmental Research journal 19122 Corvinus University of Budapest 48 0.84
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
Journal of International Financial Management and Accounting journal 1434 Wiley-Blackwell Publishing Ltd 50 10.53
Sapporo Medical Journal journal 29756 Sapporo Medical University 3 0.00
Journal des Professionnels de l'Enfance journal 30098 TPMA 2 0.00
Proceedings of the Royal Society of Queensland journal 28017 Royal Society of Queensland 12 0.17
Psycho-Oncologie journal 24496 Tech Science Press 12 0.35
Himalayan Geology journal 19942 Wadia Institute of Himalayan Geology 20 0.89

Check complete list




Year wise Impact Score (IS) of Therapeutic Advances in Infectious Disease

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.28
2023 3.25
2022 4.04
2021 3.49
2020 3.26
2019 3.14
2018 5.52
2017 7.00
2016 2.67
2015 2.00
2014 0.79



Top Journals/Conferences in Infectious Diseases

Nature Reviews Microbiology
Nature Research | United Kingdom

Immunity
Cell Press | United States

Cellular and Molecular Immunology
Springer Nature | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet Infectious Diseases, The
Elsevier Ltd | United Kingdom

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Lancet Microbe, The
Elsevier Ltd | United Kingdom

Lancet HIV,The
Elsevier Ltd | United Kingdom

Gut Microbes
Landes Bioscience | United States

FEMS Microbiology Reviews
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All